According to BlockBeats news on August 13, data from Rockflow shows that U.S. medical technology company ProPhase Labs rose over 35% during trading, increasing its market value to 15.78 million dollars. It once rose over 40% in pre-market trading.
ProPhase Labs announced on July 21 that it is exploring a reverse merger with a company focused on cryptocurrency and will begin holding Bitcoin as part of a new digital asset reserve strategy.
